Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Tough talks likely over DuPont

Article Abstract:

E.I. du Pont de Nemours and Co. is attempting to acquire all outstanding shares of its subsidiary DuPont Canada Inc. DuPont, which is offering $21 per share for its Canadian subsidiary, said it would sell the subsidiary if shareholders refuse the takeover offer.

Author: Robinson, Allan
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


DuPont wins investor battle

Article Abstract:

DuPont Canada Inc., which is led by chief executive officer Doug Muzyka, is expected to go private following approval of a plan for the company to become a wholly-owned entity of E.I. du Pont de Nemours and Co. DuPont Canada will be acquired for $1.4 billion.

Author: Adrangi, Sahm
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Canada, Mergers, acquisitions and divestments, Company acquisition/merger, Chemical industry, E.I. du Pont de Nemours and Co., DuPont Canada Inc.
Similar abstracts:
  • Abstracts: Nygard makes bid for Cotton Ginny. Aritzia eyes growth with new U.S. investor. Cotton Ginny given creditor protection
  • Abstracts: No place like home. Inside with the insiders. Morality by decree
  • Abstracts: It's here, Johnny. The investor: buck's fizz. Lend me your fears
  • Abstracts: Algoma to axe 600, cut costs in lastest bid to stay profitable. Union says job cuts loom at Daimler
  • Abstracts: Bank may offer Royal group documents. Montreal lawyer sued in Portus case
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.